PF614 PATIENT-REPORTED OUTCOMES FROM THE INNOVATE™ STUDY: RESULTS OF IBRUTINIB-RITUXIMAB IN WALDENSTRÖM MACROGLOBULINEMIA (WM)

A. Tedeschi; M.A. Dimopoulos; J. Trotman; R. García-Sanz; D. Macdonald; B. Mahe; C. Herbaux; L.T. Heffner; C.S. Tam; M. Varettoni; M.L. Palomba; J.V. Matous; C. Shustik; E. Kastritis; S.P. Treon; J. Li; E.G. Poulsen; B. Hauns; C. Buske; V. Leblond

doi:10.1097/01.HS9.0000560744.31107.FC

PF614 PATIENT-REPORTED OUTCOMES FROM THE INNOVATE™ STUDY: RESULTS OF IBRUTINIB-RITUXIMAB IN WALDENSTRÖM MACROGLOBULINEMIA (WM)

A. Tedeschi
, M.A. Dimopoulos
, J. Trotman
, R. García-Sanz
, D. Macdonald
, B. Mahe
, C. Herbaux
, L.T. Heffner
, C.S. Tam
, M. Varettoni
, M.L. Palomba
, J.V. Matous
, C. Shustik
, E. Kastritis
, S.P. Treon
, J. Li
, E.G. Poulsen
, B. Hauns
, C. Buske
, V. Leblond

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	HemaSphere
Volume	3
DOIs	https://doi.org/10.1097/01.HS9.0000560744.31107.FC
State	Published - Jun 1 2019

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1097/01.HS9.0000560744.31107.FCLicense: Unspecified

Cite this

Tedeschi, A., Dimopoulos, M. A., Trotman, J., García-Sanz, R., Macdonald, D., Mahe, B., Herbaux, C., Heffner, L. T., Tam, C. S., Varettoni, M., Palomba, M. L., Matous, J. V., Shustik, C., Kastritis, E., Treon, S. P., Li, J., Poulsen, E. G., Hauns, B., Buske, C., & Leblond, V. (2019). PF614 PATIENT-REPORTED OUTCOMES FROM THE INNOVATE™ STUDY: RESULTS OF IBRUTINIB-RITUXIMAB IN WALDENSTRÖM MACROGLOBULINEMIA (WM). HemaSphere, 3. https://doi.org/10.1097/01.HS9.0000560744.31107.FC

Tedeschi, A, Dimopoulos, MA, Trotman, J, García-Sanz, R, Macdonald, D, Mahe, B, Herbaux, C, Heffner, LT, Tam, CS, Varettoni, M, Palomba, ML, Matous, JV, Shustik, C, Kastritis, E, Treon, SP, Li, J, Poulsen, EG, Hauns, B, Buske, C & Leblond, V 2019, 'PF614 PATIENT-REPORTED OUTCOMES FROM THE INNOVATE™ STUDY: RESULTS OF IBRUTINIB-RITUXIMAB IN WALDENSTRÖM MACROGLOBULINEMIA (WM)', HemaSphere, vol. 3. https://doi.org/10.1097/01.HS9.0000560744.31107.FC

@article{109a20bfe5314bd887a3927100710449,

title = "PF614 PATIENT-REPORTED OUTCOMES FROM THE INNOVATE{\texttrademark} STUDY: RESULTS OF IBRUTINIB-RITUXIMAB IN WALDENSTR{\"O}M MACROGLOBULINEMIA (WM)",

author = "A. Tedeschi and M.A. Dimopoulos and J. Trotman and R. Garc{\'i}a-Sanz and D. Macdonald and B. Mahe and C. Herbaux and L.T. Heffner and C.S. Tam and M. Varettoni and M.L. Palomba and J.V. Matous and C. Shustik and E. Kastritis and S.P. Treon and J. Li and E.G. Poulsen and B. Hauns and C. Buske and V. Leblond",

year = "2019",

month = jun,

day = "1",

doi = "10.1097/01.HS9.0000560744.31107.FC",

language = "American English",

volume = "3",

journal = "HemaSphere",

publisher = "Wiley",

}

TY - JOUR

T1 - PF614 PATIENT-REPORTED OUTCOMES FROM THE INNOVATE™ STUDY: RESULTS OF IBRUTINIB-RITUXIMAB IN WALDENSTRÖM MACROGLOBULINEMIA (WM)

AU - Tedeschi, A.

AU - Dimopoulos, M.A.

AU - Trotman, J.

AU - García-Sanz, R.

AU - Macdonald, D.

AU - Mahe, B.

AU - Herbaux, C.

AU - Heffner, L.T.

AU - Tam, C.S.

AU - Varettoni, M.

AU - Palomba, M.L.

AU - Matous, J.V.

AU - Shustik, C.

AU - Kastritis, E.

AU - Treon, S.P.

AU - Li, J.

AU - Poulsen, E.G.

AU - Hauns, B.

AU - Buske, C.

AU - Leblond, V.

PY - 2019/6/1

Y1 - 2019/6/1

UR - https://journals.lww.com/10.1097/01.HS9.0000560744.31107.fc

U2 - 10.1097/01.HS9.0000560744.31107.FC

DO - 10.1097/01.HS9.0000560744.31107.FC

M3 - Article

VL - 3

JO - HemaSphere

JF - HemaSphere

ER -

PF614 PATIENT-REPORTED OUTCOMES FROM THE INNOVATE™ STUDY: RESULTS OF IBRUTINIB-RITUXIMAB IN WALDENSTRÖM MACROGLOBULINEMIA (WM)

Disciplines

Access to Document

Other files and links

Cite this